Structure-activity relationships for DNA damage by alkenylbenzenes in Turkey egg fetal liver

Toxicological Sciences

Volumn 150, Issue 2, 2016, Pages 301-311

  Kobets, Tetyana ^a   Duan, Jian Dong ^a   Brunnemann, Klaus D ^a   Etter, Sylvain ^b   Smith, Benjamin ^c   Williams, Gary M ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b Analysis and Perception Department   (Switzerland)

^c Firmenich Inc   (United States)

Author keywords

Alkenylbenzenes (AB); Carcinogenicity; Chemical structure; Genotoxicity; Turkey Egg Genotoxicity Assay (TEGA)

Indexed keywords

ALKENYL GROUP; ANETHOLE; BENZENE DERIVATIVE; CARCINOGEN; DNA; ELEMICIN; ESTRAGOLE; EUGENOL; ISOEUGENOL; METHYL EUGENOL; METHYL ISOEUGENOL; MYRISTICIN; SAFROLE; UNCLASSIFIED DRUG; 1,3 BENZODIOXOLE DERIVATIVE; DNA ADDUCT; FLAVORING AGENT;

ANIMAL EXPERIMENT; ARTICLE; CARCINOGENICITY; COMET ASSAY; COMPARATIVE STUDY; CONTROLLED STUDY; DNA ADDUCT; DNA BINDING; DNA DAMAGE; DNA STRAND BREAKAGE; EGG; FEMALE; FETOTOXICITY; FETUS; FETUS LIVER; GENOTOXICITY; GENOTOXICITY ASSAY; ISOTOPE LABELING; MELEAGRIS GALLOPAVO; NONHUMAN; STRUCTURE ACTIVITY RELATION; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECTS; EMBRYO DEVELOPMENT; EMBRYOLOGY; GENETICS; LIVER; METABOLISM; MUTAGEN TESTING; PATHOLOGY; TURKEY (BIRD);

ANIMALS; BENZENE DERIVATIVES; BENZODIOXOLES; COMET ASSAY; DNA ADDUCTS; DNA DAMAGE; EMBRYONIC DEVELOPMENT; FLAVORING AGENTS; LIVER; MOLECULAR STRUCTURE; MUTAGENICITY TESTS; STRUCTURE-ACTIVITY RELATIONSHIP; TURKEYS;

EID: 84964702640     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfv322     Document Type: Article

References (63)

1. Anthony, A., Caldwell, J., Hutt, A. J., and Smith, R. L. (1987). Metabolism of estragole in rat and mouse and influence of dose size on excretion of the proximate carcinogen 10- hydroxyestragole. Food Chem. Toxicol. 25, 799-806.
2. Auerbach, S. S., Shah, R. R., Mav, D., Smith, C. S., Walker, N. J., Vallant, M. K., Boorman, G. A., and Irwin, R. D. (2010). Predicting the hepatocarcinogenic potential of alkenylbenzene flavoring agents using toxicogenomics and machine learning. Toxicol. Appl. Pharmacol. 243, 300-314.
3. Borchert, P., Miller, J. A., Miller, E. C., and Shires, T. K. (1973). 10- Hydroxysafrole, a proximate carcinogenic metabolite of safrole in the rat and mouse. Cancer Res. 33, 590-600.
4. Bradley, M. O. (1985). Measurement of DNA single-strand breaks by alkaline elution in rat hepatocytes. In Progress in Mutation Research. Evaluation of Short-Term Tests for Carcinogens (J. Ashby, F. J. de Serres, M. Draper, M. Ishidate Jr, B. H. Margolin, B. E. Matter, and M. D. Shelby, Eds.), Vol. 5, pp. 353-357. Elsevier, New York, NY.
5. Bristol, D. W. (2011). NTP 3-month toxicity studies of estragole (CAS No. 140-67-0) administered by gavage to F344/N rats and B6C3F1 mice. National Toxicology Program Toxicity Report Series Number 82. NIH Publication No. 08- 5966. pp. 1-111.
6. Burkey, J. L., Sauer, J. M., McQueen, C. A., and Sipes, I. G. (2000). Cytotoxicity and genotoxicity of methyleugenol and related congeners--A mechanism of activation for methyleugenol. Mutat. Res. 453, 25-33.
7. Caldwell, J., and Sutton, J. D. (1988). Influence of dose size on the disposition of trans-[methoxy-14C]anethole in human volunteers. Food Chem. Toxicol. 26, 87-91.
8. Cartus, A. T., Merz, K. H., and Schrenk, D. (2011). Metabolism of methylisoeugenol in liver microsomes of human, rat, and bovine origin. Drug Metab. Dispos. 39, 1727-1733.
9. Cartus, A. T., Stegmüller, S., Simson, N., Wahl, A., Neef, S., Kelm, H., and Schrenk, D. (2015). Hepatic metabolism of carcinogenic beta-asarone. Chem. Res. Toxicol. 28, 1760-1773.
10. Chen, C. L., Chi, C. W., Chang, K. W., and Liu, T. Y. (1999). Safrolelike DNA adducts in oral tissue from oral cancer patients with a betel quid chewing history. Carcinogenesis 20, 2331- 2334.
11. Chiang, S. Y., Lee, P. Y., Lai, M. T., Shen, L. C., Chung, W. S., Huang, H. F., Wu, K. Y., and Wu, H. C. (2011). Safrole-20,30-oxide induces cytotoxic and genotoxic effects in HepG2 cells and in mice. Mutat. Res. 726, 234-241.
12. Ding, W., Levy, D. D., Bishop, M. E., Pearce, M. G., Davis, K. J., Jeffrey, A. M., Duan, J. D., Williams, G. M., White, G. A., Lyn- Cook, L. E., et al. (2015). In vivo genotoxicity of estragole in male F344 rats. Environ. Mol. Mutagen. 56, 356-365.
13. Drinkwater, N. R., Miller, E. C., Miller, J. A., and Pitot, H. C. (1976). Hepatocarcinogenicity of estragole (1-allyl-4-methoxybenzene) and 10-hydroxyestragole in the mouse and mutagenicity of 10-acetoxyestragole in bacteria. J. Natl Cancer Inst. 57, 1323-1331.
14. Enzmann, H., Brunnemann, K., Iatropoulos, M., Shpyleva, S., Lukanova, N., Todor, I., Moore, M., Spicher, K., Chekhun, V., Tsuda, H., et al. (2013). Inter-laboratory comparison of turkey in ovo carcinogenicity assessment (IOCA) of hepatocarcinogens. Exp. Toxicol. Pathol. 65, 729-735.
15. Enzmann, H., Kaliner, G., Watta-Gebert, B., and Loser, E. (1992). Foci of altered hepatocytes induced in embryonal turkey liver. Carcinogenesis 13, 943-946.
16. Fischer, I. U., von Unruh, G. E., and Dengler, H. J. (1990). The metabolism of eugenol in man. Xenobiotica 20, 209-222.
17. Garaj-Vrhovac, V., and Kopjar, N. (2003). The alkaline Comet assay as biomarker in assessment of DNA damage in medical personnel occupationally exposed to ionizing radiation. Mutagenesis 18, 265-271.
18. Gardner, I., Wakazono, H., Bergin, P., de Waziers, I., Beaune, P., Kenna, J. G., and Caldwell, J. (1997). Cytochrome P450 mediated bioactivation of methyleugenol to 10-hydroxymethyleugenol in Fischer 344 rat and human liver microsomes. Carcinogenesis 18, 1775-1783.
19. Gorelick, N. J. (1995). Genotoxicity of trans-anethole in vitro. Mutat. Res. 326, 199-209.
20. Guenthner, T. M., and Luo, G. (2001). Investigation of the role of the 20,30-epoxidation pathway in the bioactivation and genotoxicity of dietary allylbenzene analogs. Toxicology 160, 47-58.
21. Hamilton, J. W., Denison, M. S., and Bloom, S. E. (1983). Development of basal and induced aryl hydrocarbon (benzo[ a]pyrene) hydroxylase activity in the chicken embryo in ovo. Proc. Natl. Acad. Sci. U.S.A. 80, 3372-3376.
22. Hasheminejad, G., and Caldwell, J. (1994). Genotoxicity of the alkenylbenzenes alpha- and beta-asarone, myristicin and elimicin as determined by the UDS assay in cultured rat hepatocytes. Food Chem. Toxicol. 32, 223-231.
23. Herrmann, K., Schumacher, F., Engst, W., Appel, K. E., Klein, K., Zanger, U. M., and Glatt, H. (2013). Abundance of DNA adducts of methyleugenol, a rodent hepatocarcinogen, in human liver samples. Carcinogenesis 34, 1025-1030.
24. Howes, A. J., Chan, V. S., and Caldwell, J. (1990). Structurespecificity of the genotoxicity of some naturally occurring alkenylbenzenes determined by the unscheduled DNA synthesis assay in rat hepatocytes. Food Chem. Toxicol. 28, 537-542.
25. International Agency for Research on Cancer (IARC) (1976). Safrole, isosafrole and dihydrosafrole. In Some Naturally Occurring Substances, Vol. 10, pp. 231-244. International Agency for Research on Cancer, Lyon, France. IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Humans.
26. Kawaguchi, S., Nakamura, T., Yamamoto, A., Honda, G., and Sasaki Y. F. (2010). Is the comet assay a sensitive procedure for detecting genotoxicity? J. Nucleic Acids 2010, 541050.
27. Kim, S. G., Liem, A., Stewart, B. C., and Miller, J. A. (1999). New studies on trans-anethole oxide and trans-asarone oxide. Carcinogenesis 20, 1303-1307.
28. Lancaster, M. C., Jenkins, F. P., and Philp, J. (1961). Toxicity associated with certain samples of groundnuts. Nature 192, 1095- 1096.
29. Lee, J. M., Liu, T. Y., Wu, D. C., Tang, H. C., Leh, J., Wu, M. T., Hsu, H. H., Huang, P. M., Chen, J. S., Lee, C. J., et al. (2005). Safrole- DNA adducts in tissues from esophageal cancer patients: Clues to areca-related esophageal carcinogenesis. Mutat. Res. 565, 121-128.
30. Marshall, A. D., and Caldwell, J. (1991). Modulation of epoxide metabolism enhances the cytotoxicity but not the genotoxicity of the food flavour anethole. Hum. Exp. Toxicol. 10, 486- 487.
31. Miller, E. C., Swanson, A. B., Phillips, D. H., Fletcher, T. L., Liem, A., and Miller, J. A. (1983). Structure-activity studies of the carcinogenicities in the mouse and rat of some naturally occurring and synthetic alkenylbenzene derivatives related to safrole and estragole. Cancer Res. 43, 1124-1134.
32. Miller, J. A., Swanson, A. B., and Miller, E. C. (1979). The metabolic activation of safrole and related naturally occurring alkenylbenzenes in relation to their carcinogenesis by these agents. In Naturally Occuring Carcinogens-Mutagens and Modulators of Carcinogenesis. (E. C.Miller, Ed.), pp. 111-125. Japanese Scientific Societies Press, Tokyo/University Park Press, Baltimore.
33. National Toxicology Program(NTP) (1983). Carcinogenesis studies of eugenol (CAS No. 97-53-0) in F344/N rats and B6C3F1 mice (feed studies). National Toxicology Program Toxicity Report Series Number 223, NIH publication No. 84-1779. pp. 1-159.
34. National Toxicology Program (NTP) (2000). NTP toxicology and carcinogenesis studies of methyleugenol (CAS NO. 93-15-2) in F344/N rats and B6C3F1 mice (gavage studies). National Toxicology Program Toxicity Report Series Number 491, NIH publication No. 00-3950. pp. 1-412.
35. National Toxicology Program (NTP) (2010). Toxicology and carcinogenesis studies of isoeugenol (CAS No. 97-54-1) in F344/N rats and B6C3F1 mice (gavage studies). National Toxicology Program Toxicity Report Series Number 551, NIH Publication No. 10-5892. pp. 1-178.
36. Newberne, P., Smith, R. L., Doull, J., Goodman, J. I., Munro, I. C., Portoghese, P. S., Wagner, B. M., Weil, C. S., Woods, L. A., Adams, T. B., et al. (1999). The FEMA GRAS assessment of trans-anethole used as a flavor substance. Flavour and Extract Manufacturer's Association. Food Chem. Toxicol. 37, 789-811.
37. OECD (2014). Test No. 489: In Vivo Mammalian Alkaline Comet Assay. OECD Guidelines for the Testing of Chemicals. Section 4. OECD Publishing, Paris.
38. Paini, A., Scholz, G., Marin-Kuan, M., Schilter, B., O'Brien, J., van Bladeren, P. J., and Rietjens, I. M. (2011). Quantitative comparison between in vivo DNA adduct formation from exposure to selected DNA-reactive carcinogens, natural background levels of DNA adduct formation and tumor incidence in rodent bioassays. Mutagenesis 26, 605-618.
39. Perrone, C. E., Ahr, H. J., Duan, J. D., Jeffrey, A. M., Schmidt, U., Williams, G. M., and Enzmann, H. H. (2004). Embryonic turkey liver: Activities of biotransformation enzymes and activation of DNA-reactive carcinogens. Arch. Toxicol. 78, 589-598.
40. Phillips, D. H., Farmer, P. B., Beland, F. A., Nath, R. G., Poirier, M. C., Reddy, M. V., and Turteltaub, K.W. (2000). Methods of DNA adduct determination and their application to testing compounds for genotoxicity. Environ. Mol. Mutagen. 35, 222-233.
41. 32P-postlabelling analysis of DNA adducts formed in the livers of animals treated with safrole, estragole and other naturallyoccurring alkenylbenzenes. II. Newborn male B6C3F1 mice. Carcinogenesis 5, 1623-1628.
42. Purchase, R., Ford, G. P., Creasy, D. M., Brantom, P. G., and Gangolli, S. D. (1992). A 28-day feeding study with methyl isoeugenol in rats. Food Chem. Toxicol. 30, 475-481.
43. 32P-postlabeling analysis of DNA adducts formed in the livers of animals treated with safrole, estragole and other naturally-occurring alkenylbenzenes. I. Adult female CD-1 mice. Carcinogenesis 5, 1613-1622.
44. 32P-Labeling test for DNA damage. Proc. Natl. Acad. Sci. U.S.A. 78, 6126- 6129.
45. Rietjens, I. M., Boersma, M. G., van der Woude, H., Jeurissen, S.M. F., Schutte, M. E., and Alink, G. M. (2005). Flavonoids and alkenylbenzenes: mechanisms of mutagenic action and carcinogenic risk. Mutat. Res. 574, 124-138.
46. Rietjens, I. M., Cohen, S. M., Fukushima, S., Gooderham, N. J., Hecht, S., Marnett, L. J., Smith, R. L., Adams, T. B., Bastaki, M., Harman, C. G., et al. (2014). Impact of structural and metabolic variations on the toxicity and carcinogenicity of hydroxy- and alkoxy-substituted allyl- and propenylbenzenes. Chem. Res. Toxicol. 27, 1092-1103.
47. Rifkind, A. B., Troeger, M., and Petschke, T. (1979). Equality of the rates of mixed function oxidation in livers of male and female chick embryos. Biochem. Pharmacol. 28, 1681-1683.
48. Sangster, S. A., Caldwell, J., Anthony, A., Hutt, A. J., and Smith, R. L. (1987). The metabolic disposition of [methoxy-14C]-labeled trans-anethole, estragole and p-proylanisole in human volunteers. Xenobiotica 17, 1223-1232.
49. Sekizawa, J., and Shibamoto, T. (1982). Genotoxicity of safrolerelated chemicals in microbial test systems. Mutat. Res. 101, 127-140.
50. Smith, R. L., Adams, T. B., Doull, J., Feron, V. J., Goodman, J. I., Marnett, L. J., Portoghese, P. S., Waddell, W. J., Wagner, B. M., Rogers, A. E., et al. (2002). Safety assessment of allylalkoxybenzene derivatives used as flavouring substances--Methyl eugenol and estragole. Food Chem. Toxicol. 40, 851-870.
51. Solheim, E., and Scheline, R. R. (1976). Metabolism of alkenebenzene derivatives in the rat. II. Eugenol and isoeugenol methyl ethers. Xenobiotica 6, 137-150.
52. Stening, P., Gardner, I., Kenna, J. G., Coughtric, M. W. H., and Caldwell, J. (1997). Formation of alkenylbenzene macromolecular adducts in human fibroblast V79 cells transfected with human sulfotransferases. Hum. Exp. Toxicol. 16, 62.
53. Tice, R. R., and Strauss, G. H. (1995). The single cell gel electrophoresis/ comet assay: a potential tool for detecting radiation-induced DNA damage in humans. Stem Cells 13, 207-214.
54. Truhaut, R., Le Bourhis, B., Attia, M., Glomot, R., Newman, J., and Caldwell, J. (1989). Chronic toxicity/carcinogenicity study of trans-anethole in rats. Food Chem. Toxicol. 27, 11-20.
55. U.S. Food and Drug Administration (USFDA) (2010). Code of Federal Regulations. Title 21, Vol. 3, 21CFR172.515. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/ CFRSearch.cfm?fr=172.515.
56. van den Berg, S. J., Punt, A., Soffers, A. E., Vervoort, J., Ngeleja, S., Spenkelink, B., and Rietjens, I. M. (2012). Physiologically based kinetic models for the alkenylbenzene elemicin in rat and human and possible implications for risk assessment. Chem. Res. Toxicol. 25, 2352-2367.
57. van der Leede, B. J., Doherty, A., Guérard, M., Howe, J., O'Donovan, M., Plappert-Helbig, U., and Thybaud, V. (2014). Performance and data interpretation of the in vivo comet assay in pharmaceutical industry: EFPIA survey results. Mutat. Res. Genet. Toxicol. Environ. Mutagen. 775-776, 81-88.
58. Williams, G. M., and Mattia, A. (2009). Alkoxy-substituted allylbenzenes present in foods and essential oils and used as flavouring agents. In Data Safety Evaluation of Certain Food Additives/Prepared by the Sixty-Ninth Meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA). WHO food additives series 60. pp. 352-480.
59. Williams, G. M., Duan, J. D., Brunnemann, K. D., Iatropoulos, M. J., Vock, E., and Deschl, U. (2014). Chicken fetal liver DNA damage and adduct formation by activation-dependent DNA-reactive carcinogens and related compounds of several structural classes. Toxicol. Sci. 141, 18-28.
60. Williams, G. M., Iatropoulos, M. J., Jeffrey, A. M., and Duan, J. D. (2013). Methyleugenol hepatocellular cancer initiating effects in rat liver. Food Chem. Toxicol. 53, 187-196.
61. Williams, J. G., Deschl, U., and Williams, G. M. (2011). DNA damage in fetal liver cells of turkey and chicken eggs dosed with aflatoxin B1. Arch. Toxicol. 85, 1167-1172.
62. Wislocki, P. G., Miller, E. C., Miller, J. A., McCoy, E. C., and Rosenkranz, H. S. (1977). Carcinogenic and mutagenic activities of safrole, 10-hydroxysafrole, and some known or possible metabolites. Cancer Res. 37, 1883-1891.
63. Zhou, G. D., Moorthy, B., Bi, J., Donnelly, K. C., and Randerath, K. (2007). DNA adducts from alkoxyallylbenzene herb and spice constituents in cultured human (HepG2) cells. Environ. Mol. Mutagen. 48, 715-721.